More specifically, previous studies demonstrated that RANKL mediates progesterone-driven mammary carcinogenesis [8,9,10] and RANK/RANKL signalling controlled BRCA1 mutation-driven mammary tumours [11]. The gene discussed is BRCA1; the disease is breast cancer.